News Center
With the tenet of "Healthy China, Dedicated commitment", Linuo Pharmaceuticals increases cooperation and association with external scientific research institutes while innovating and developing independently.
01
2025
-
12
The first year ushers in a new beginning—returning with honors! Keyuan Pharmaceutical and Linuo Pharmaceutical have won multiple prestigious awards at the Group’s celebration!
Classification：
行业新闻
Corporate News
Staff Style
Recently, the 31st-anniversary gala of Linuo Group was held with great splendor in Jinan. Keyuan Pharmaceutical (stock code: 301281.SZ) and Linuo Pharmaceutical have been reporting frequent good news, winning numerous individual and collective awards in the recognition of meritorious achievements. Moreover, during the cultural and artistic performance, the team showcased its vibrant and uplifting spirit through outstanding performances, achieving a double win of both business results and cultural enrichment.
During the highly anticipated awards ceremony, Outstanding representatives from the management teams, core executives, and frontline employees of Keyuan Pharmaceutical and Linuo Pharmaceutical have all been recognized with prestigious awards. The scope of these awards spans multiple key areas—including management, marketing, production, supply chain, and quality—demonstrating the comprehensiveness and high caliber of the companies’ talent pool. Meanwhile, both companies have jointly received numerous awards for advanced collective achievements. This well-deserved recognition is the highest honor bestowed upon the companies’ overall operations and team collaboration capabilities.
On the stage of honor, their talents were no less impressive. At the subsequent cultural gala, Linuo Pharmaceutical won thunderous applause with their performance titled "Qilin Brings Auspiciousness." Adapted show "Dragon Clan" By weaving the corporate spirit and development blueprint into the lyrics, the passionate singing of Linuo Pharmaceutical’s employees expresses their confidence and bold aspirations. Keyuan Pharmaceutical highlighted its international perspective and precise strategic planning during the celebration. Through a solemn oath, the company conveyed its original commitment to safeguarding health and outlined its vision more clearly. “ Top 100 in Five Years ” The development blueprint.
This comprehensive success at the group’s celebration is a microcosm of Kexuan Pharmaceutical and Linuo Pharmaceutical’s outstanding performance over the past year. Filled with honors, as we embark on a new journey, every member of the company will surely take this as a fresh starting point. With a more vigorous spirit and more pragmatic actions, let us forge ahead with determination and create new glories.
Related news
2026-05-18
On May 16–17, Wu Xiaobo, known as “China’s foremost financial writer” and a renowned entrepreneur, led a delegation to visit and inspect Keyuan Pharmaceutical (stock code: 301281.SZ). The group focused on the company’s achievements in integrating smart manufacturing with digital AI technologies in the pharmaceutical sector, engaged in in-depth discussions with its core management team, and expressed high praise for the company’s practical approach to driving industrial upgrading through digital and intelligent transformation. Gao Yuankun, Chairman and President of Linuo Group, along with Li Hongfu, Chairman of Keyuan Pharmaceutical, and Wei Zhiguo, President of the company, accompanied the delegation during the visit.
2026-05-13
On May 13, the 92nd National Pharmaceutical Fair and the 94th China International API, Intermediate, Packaging & Equipment Exhibition (API China) opened in grand style at the Shanghai National Exhibition and Convention Center. As an innovative, publicly listed company in China’s chemical pharmaceutical sector, Shandong Keyuan Pharmaceutical Co., Ltd. (301281.SZ), together with its wholly owned subsidiary Shandong Linuo Pharmaceutical Co., Ltd., made a high‑profile appearance, showcasing a coordinated approach to APIs and finished dosage forms, a comprehensive end-to-end product portfolio, and strong brand synergy. The company highlighted its robust capabilities in innovative R&D, digital and intelligent manufacturing, green production, global supply chains, and clinical translation, while engaging domestic and international partners to explore emerging industry trends, expand new avenues of collaboration, and co‑create a thriving new ecosystem for the pharmaceutical and healthcare sectors.
2026-05-07
On May 6, Lino Pharmaceutical, a subsidiary of Keyuan Pharmaceutical (stock code: 301281.SZ), held a company-wide meeting in Jinan. Centered on the core principle of “unified strategy across the entire workforce and coordinated action across all business units,” the meeting comprehensively communicated the company’s development strategy and outlined the implementation roadmap, aligning the thinking and building consensus among all employees. With a spirit of concerted effort and synchronized momentum, the meeting charted a new blueprint for the company’s high-quality development.
2026-05-07
Recently, the Jinan Municipal Federation of Trade Unions officially announced the list of winners for the 2025 “Making Contributions in the Spring City” Innovation and Excellence Labor Competition. Shandong Linuo Pharmaceutical Co., Ltd.’s Solid Dosage Form Workshop stood out among numerous outstanding work teams across the city thanks to its remarkable performance, rigorous work style, and exceptional innovative capabilities, earning the prestigious First Prize for Work Teams.
ADD：#30766 Jingshidong Road, Linuo High-tech Park, Jinan, Shandong Province, P. R. China